Toxic epidermal necrolysis after cranial radiotherapy and phenytoin treatment

Onkologie

Volumn 27, Issue 4, 2004, Pages 389-392

  Dincbas, Fazilet Oner ^a,b   Yoruk S ^c   Demirkesen, C ^b   Uzel, O ^a   Koca, S ^a  

^a Department of Radiation Oncology ^*  (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Turkish Cancer Society   (Turkey)

Author keywords

Brain irradiation; Phenytoin; Toxic epidermal necrolysis

Indexed keywords

DEXAMETHASONE; PHENYTOIN;

ADULT; ARTICLE; BLISTER; BRAIN METASTASIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; DEATH; DISEASE SEVERITY; EDEMA; ERYTHEMA; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PAPULE; RASH; SEIZURE; SKIN MANIFESTATION; SKULL IRRADIATION; STEVENS JOHNSON SYNDROME; SUPERINFECTION; TOXIC EPIDERMAL NECROLYSIS;

AGED; ANTICONVULSANTS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; EPIDERMAL NECROLYSIS, TOXIC; FATAL OUTCOME; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PALLIATIVE CARE; PHENYTOIN; RISK FACTORS; SEIZURES; STEVENS-JOHNSON SYNDROME;

EID: 4644307417     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079094     Document Type: Article

References (20)

1. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F: Medication use and risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis. N Eng J Med 1995;333:1600-1607.
2. Bastuji-Garin S, Rzany B, Stern R, Shear NH, Naldi L, Roujeau JC: Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-96.
3. Huff JC, Weston WL, Tonnesen MG: Erythema multiforme: A critical review of characteristics, diagnostic criteria and causes. J Am Acad Dermatol 1983;8:763-775.
4. Delattre JY, Safai B, Posner JB: Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 1988;38:194-198.
5. Maiche A, Teerenhovi L: Stevens-Johnson syndrome in patients receiving radiation therapy. Lancet 1985;45:8445.
6. Janinis J, Panagos G, Panousaki A, Skarlos D, Athanasiou E, Karpasitis N, Pirounaki M: Stevens-Johnson syndrome and epidermal necrolysis after administration of sodium phenytoin with cranial irradiation. Eur J Cancer 1993;29A:478-479.
7. Cockey GH, Amann ST, Reents SB, Lynch JW Jr.: Stevens-Johnson syndrome resulting from whole brain radiation and phenytoin. Am J Clin Oncol 1996;19:32-34.
8. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R: Risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: A case control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet 1999;353:2190-2194.
9. Hess DA, Reider MJ: The role of reactive drug metabolites in immune-mediated adverse drug reactions. Ann Pharmacother 1997;31:1378-1387.
10. Delafuente JC: Drug-induced erythema multiforme: A possible immunologic pathogenesis. Drug Intell Clin Pharm 1985;19:114-117.
11. Inachi S, Mizutani H, Shimizu M: Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson Syndrome. Contribution of perform-positive cell infiltration. Arch Dermatol 1997;133:845-849.
12. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Pierard GE: Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 1994;130:605-608.
13. Duncan KO, Tigelaar RE, Bolognia JL: Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital. J Am Acad Dermatol 1999;40:493-496.
14. Tegelberg-Stassen MJ, van Vloten WA, Baart de la Faille H: Management of nonstaphylococcal toxic epidermal necrolysis: Follow-up study of 16 case histories. Dermalogica 1990;180:124-129.
15. Patterson R, Dykewicz MS, Gonzalzles A, Grammer LC, Green D, Greenberger PA, McGrath KG, Walker CL: Erythema multiforme and Stevens-Johnson Syndrome. Descriptive and therapeutic controversy. Chest 1990;98:331-336.
16. Heng MC, Allen SG: Efficacy of cyclophosphamide in toxic epidermal necrolysis. Clinical and pathophysiologic aspects. J Am Acad Dermatol 1991;25:778-786.
17. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE: Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-493.
18. Bachot N, Roujeau JC: Intravenous immunoglobulins in the treatment of severe drug eruptions. Curr Opin Allergy Clin Immunol 2003;3:269-274.
19. Cohen N, Strauss G, Lew R, Silver D, Recht L: Should prophylactic anticonvulsants be administered to patients with newly diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 1988;6:1621-1624.
20. Byrne TN, Cascino TL, Posner JB: Brain metastases from melanoma. J Neurooncol 1983;1:313-317.